StageWise Strategies Secures $250K from Controlling Shareholder at Deep Discount

summarizeSummary

StageWise Strategies received a $250,000 capital injection from its controlling shareholder by issuing 1,000,000 shares at a deep discount, addressing its previously disclosed zero cash position and going concern issues.

check_boxKey Events · Financing and Capital Events · STWI

• Capital Infusion

  StageWise Strategies entered a Share Subscription Agreement to sell 1,000,000 shares for $250,000 to its controlling shareholder, Jakhongir Abidovich Artikkhodjaev.

• Deep Discount Pricing

  The shares are being issued at $0.25 per share, representing a substantial discount compared to the current market price of $0.4724.

• Addressing Financial Distress

  This capital raise directly follows previous disclosures of zero cash and significant going concern doubts, providing critical funding for the company's operations.

• Controlling Shareholder Commitment

  The funding comes from the company's controlling shareholder, who recently acquired a 74.2% stake, indicating their commitment to the company's viability despite the unfavorable terms.

auto_awesomeAnalysis · STWI · Technology

This filing details a critical capital infusion for StageWise Strategies, which previously reported zero cash and going concern doubts. The company is selling 1,000,000 shares to its controlling shareholder, Jakhongir Abidovich Artikkhodjaev, for $250,000. While this provides essential funding to extend the company's runway, the shares are being issued at $0.25 each, a significant discount to the current market price of $0.4724. This highly dilutive transaction, occurring while the stock trades near its 52-week low, underscores the company's distressed financial state and the challenges in securing capital on favorable terms.